Company: SHPH
Filing Date: 2025-04-10
Form Type: PRER14A
Source: 0001641172-25-003635
Chunk: 19

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-04-10
Form: PRER14A
Chunk 19
---
 person or by proxy at the 2025 Annual Meeting in order to be approved.

THE TEXT OF THE RESOLUTION IN RESPECT OF PROPOSAL 3 IS AS FOLLOWS:

“RESOLVED, that the Company’s stockholders approve, on an advisory basis, the compensation paid to the Company’s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K in this proxy statement in the section entitled “Executive Compensation,” including the compensation tables and narrative discussions set forth therein.”

ADVISORY VOTE ONLY

This vote is advisory, and therefore not binding on the Company, the Compensation Committee, or the Board of Directors. However, the Compensation Committee will consider the outcome of the vote when considering future executive compensation arrangements. Abstentions and broker non-votes will have no effect on the vote on this proposal.

Executive Compensation

Summary Compensation Table

The table below summarizes all compensation awarded to, earned by, or paid to our Chief Executive Officer and Chief Financial Officer and certain of our other executive officers for 2024 and 2023.

| 14 |

<div align='center'>SUMMARY COMPENSATION TABLE</div>

| Name                                
 and principal position              |     | Year |      |     | Salary 
 ($)    |         |     | Bonus 
 ($)   |         |     | Stock  
 Awards 
 ($)    |         |     | Option 
 Awards 
 ($)    |   |     | Non-Equity                      
 Incentive Plan Compensation ($) |   |     | Nonqualified                   
 Deferred Compensation Earnings 
 ($)                            |   |     | All                
 Other Compensation 
 ($)                |   |     | Total 
 ($)   |         |
| Anatoly Dritschilo M.D., CEO*       |     |      | 2024 |     |        | 274,000 |     |       |       - |     |        |       - |     |        | - |     |                                 | - |     |                                | - |     |                    | - |     |       | 274,000 |
|                                     |     |      | 2023 |     |        | 287,175 |     |       | 112,000 |     |        |       - |     |        | - |     |                                 | - |     |                                | - |     |                    | - |     |       | 399,175 |
| Timothy J. Lorber                   
 CFO**                               |     |      | 2024 |     |        |